- PROCTO3 REPORT AT Gastroenterology, Hepatobiliary, and Biliary Department - FV HOSPITAL (17/01/2024 )
- GLIGCA REPORT AT SPINE DEPARTMENT B – HCMC ORTHOPEDIC TRAUMA HOSPITAL (17/01/2024 )
- REPORT TAMDEFLO, CAPSER, VOCFOR, DEGODAS CAN THO CENTRAL GERD (17/01/2024 )
- REPORT TAMDEFLO ORTHOPEDIC TRAUMA DEPARTMENT (17/01/2024 )
- CAPSER REPORT FOR MUSCULOSCOPIC AND JOINT DEPARTMENT OF CHO RAY HOSPITAL (17/01/2024 )
- TAMDEFLO MINH DUC HOSPITALOn October 21, 2023, Medbolide Joint Stock Company had a report to introduce the product TAMDEFLO (deflazacort 6mg) at the hall of Minh Duc Hospital, Ben Tre. The report took place with the participation of more than 30 Doc (17/01/2024 )
- Report TAMDEFLO Thong Nhat Hospital (17/01/2024 )
- Report TAMDEFLO MEDIC BINH DUONG (17/01/2024 )
- GLIGCA REPORT AT THE PHARMACY DEPARTMENT - FV HOSPITAL (11/01/2024 )
- CAPSER – ENDOCRINE DEPARTMENT, CHO RAY HOSPITAL (16/10/2023 )
REPORT TAMDEFLO, CAPSER, DEGODAS – SAIGON MINDSET GENERAL HOSPITAL
On the morning of March 26, 2021, at Tam Tri Saigon General Hospital (171 Truong Chinh, Tan Thoi Nhat, District 12, Ho Chi Minh City), Medbolide Joint Stock Company had a report to introduce the product TAMDEFLO ( Deflazacort 6mg), DEGODAS (Ibandronate 2.5mg), CAPSER (Capsain 0.075%). The report took place with the participation of Doctors, Pharmacists and Nurses throughout the hospital.
Company representatives presented recommendations and clinical studies demonstrating the advantages of the active ingredients Deflazacort, Ibandronate and Capsaicin.
After the report, the doctors had many interesting discussions about how to use drugs and the overall treatment costs of drugs.
At the end of the report, the representative of Medbolide Company summarized the main points and sent thanks to the Doctors, hoping to have the opportunity to continue accompanying the Hospital and Patients.
Readers comments